The American Venous Forum (AVF) invites submissions for high-impact Late Breaking Clinical Trials and Emerging Technologies to be presented live on stage at the upcoming AVF Annual Meeting in Nashville, TN. This second call highlights top-tier, late-stage clinical research, high-potential ongoing studies, and novel innovations shaping the future of venous and lymphatic disease care.

Submission Categories & Criteria

Late Breaking Clinical Trials: This category is designed for high-impact prospective clinical trials (multicenter studies preferred) with new or late-breaking data.

• Eligibility: Completed trials or ongoing trials that will have definitive data available by the time of presentation in Nashville.
• Abstract Requirements:
  • Specific number of patients or procedures evaluated/projected.
  • Clearly defined primary and secondary endpoints/outcomes.
  • Preliminary data (priority selection will be awarded to abstracts containing preliminary results).

Emerging Technologies & Early-Stage Studies: This category focuses on novel medical devices, procedural innovations, and early-phase clinical studies.

• Eligibility: Novel technologies currently in development or early commercialization, as well as ongoing trials not expected to report final data at AVF.
• Abstract Requirements:
  • For Novel Technology: Description of clinical indication(s), mechanism of action, technical design, and intended therapeutic or diagnostic use.
  • For Early/Ongoing Studies: Detailed outline of the trial design, patient recruitment strategy, projected enrollment, target indications, and inclusion/exclusion criteria.
  • Priority: Special consideration will be given to technology in early commercialization phases and clinical trials in their first year of enrollment.